F. Jeroen Vogelaar

Maastricht University

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Maastricht University

Research Subjects

Research Interests

F. Jeroen Vogelaar has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

Eline H. van Roekel
Department of Epidemiology, GROW Research Institute for Oncology and Reproduction Maastricht University Maastricht The Netherlands
9 shared publications
Eric T. P. Keulen
Department of Internal Medicine and Gastroenterology, Zuyderland Medical Centre Sittard-Geleen, Geleen, The Netherlands
9 shared publications
Evertine Wesselink
Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands
9 shared publications
Fränzel J. B. van Duijnhoven
Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands
9 shared publications
Marlou-Floor Kenkhuis
Department of Epidemiology, GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands
9 shared publications
Martijn Jan Leo Bours
Department of Epidemiology, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands
9 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Open Access
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Open Access
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Open Access
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Open Access
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Background:Fatigue is often reported by colorectal cancer survivors and largely impacts their quality of life. Inflammation has been linked to fatigue mainly in patients with breast cancer. Therefore, we investigated how inflammation is longitudinally associated with fatigue in colorectal cancer survivors, up to 2 years posttreatment.Methods:A total of 257 patients from the ongoing Energy for life after ColoRectal cancer cohort study were included in the analysis. Plasma levels of IL6, IL8, IL10, TNFα, high-sensitivity C-reactive protein (hsCRP), and fatigue were measured at 6 weeks, 6, 12, and 24 months posttreatment. Fatigue was measured through the validated Checklist Individual Strength (CIS; total, 20–140), consisting of four subscales – subjective fatigue (8–56), motivation (4–28), physical activity (3–21), and concentration (5–35), and the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Core 30 fatigue subscale (0–100). Linear mixed-models were used to assess the confounder-adjusted longitudinal associations between inflammatory markers and overall fatigue along with the subscales.Results:Mean levels of CIS fatigue decreased from 62.9 at 6 weeks to 53.0 at 24 months. In general, levels of inflammatory markers also decreased over time. No statistically significant longitudinal associations were found between IL6, IL8, IL10, TNFα, and fatigue. Higher levels of hsCRP were associated with more CIS fatigue (β per SD 3.21, 95% confidence interval (CI), 1.42–5.01) and EORTC fatigue (β 2.41, 95% CI, 0.72–4.10).Conclusions:Increased levels of hsCRP are longitudinally associated with more posttreatment fatigue in colorectal cancer survivors.Impact:These findings suggest that low-grade inflammation may play a role in fatigue reported by colorectal cancer survivors up to 2 years posttreatment.
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Data from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Background:Fatigue is often reported by colorectal cancer survivors and largely impacts their quality of life. Inflammation has been linked to fatigue mainly in patients with breast cancer. Therefore, we investigated how inflammation is longitudinally associated with fatigue in colorectal cancer survivors, up to 2 years posttreatment.Methods:A total of 257 patients from the ongoing Energy for life after ColoRectal cancer cohort study were included in the analysis. Plasma levels of IL6, IL8, IL10, TNFα, high-sensitivity C-reactive protein (hsCRP), and fatigue were measured at 6 weeks, 6, 12, and 24 months posttreatment. Fatigue was measured through the validated Checklist Individual Strength (CIS; total, 20–140), consisting of four subscales – subjective fatigue (8–56), motivation (4–28), physical activity (3–21), and concentration (5–35), and the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Core 30 fatigue subscale (0–100). Linear mixed-models were used to assess the confounder-adjusted longitudinal associations between inflammatory markers and overall fatigue along with the subscales.Results:Mean levels of CIS fatigue decreased from 62.9 at 6 weeks to 53.0 at 24 months. In general, levels of inflammatory markers also decreased over time. No statistically significant longitudinal associations were found between IL6, IL8, IL10, TNFα, and fatigue. Higher levels of hsCRP were associated with more CIS fatigue (β per SD 3.21, 95% confidence interval (CI), 1.42–5.01) and EORTC fatigue (β 2.41, 95% CI, 0.72–4.10).Conclusions:Increased levels of hsCRP are longitudinally associated with more posttreatment fatigue in colorectal cancer survivors.Impact:These findings suggest that low-grade inflammation may play a role in fatigue reported by colorectal cancer survivors up to 2 years posttreatment.
Open Access
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Open Access
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Figure from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Open Access
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Website
Google Scholar
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Supplementary Table from Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
Website
Google Scholar
Cited by 12
- 2 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Background: Fatigue is often reported by colorectal cancer survivors and largely impacts their quality of life. Inflammation has been linked to fatigue mainly in patients with breast cancer. Therefore, we investigated how inflammation is longitudinally associated with fatigue in colorectal cancer survivors, up to 2 years posttreatment. Methods: A total of 257 patients from the ongoing Energy for life after ColoRectal cancer cohort study were included in the analysis. Plasma levels of IL6, IL8, IL10, TNFα, high-sensitivity C-reactive protein (hsCRP), and fatigue were measured at 6 weeks, 6, 12, and 24 months posttreatment. Fatigue was measured through the validated Checklist Individual Strength (CIS; total, 20–140), consisting of four subscales – subjective fatigue (8–56), motivation (4–28), physical activity (3–21), and concentration (5–35), and the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Core 30 fatigue subscale (0–100). Linear mixed-models were used to assess the confounder-adjusted longitudinal associations between inflammatory markers and overall fatigue along with the subscales. Results: Mean levels of CIS fatigue decreased from 62.9 at 6 weeks to 53.0 at 24 months. In general, levels of inflammatory markers also decreased over time. No statistically significant longitudinal associations were found between IL6, IL8, IL10, TNFα, and fatigue. Higher levels of hsCRP were associated with more CIS fatigue (β per SD 3.21, 95% confidence interval (CI), 1.42–5.01) and EORTC fatigue (β 2.41, 95% CI, 0.72–4.10). Conclusions: Increased levels of hsCRP are longitudinally associated with more posttreatment fatigue in colorectal cancer survivors. Impact: These findings suggest that low-grade inflammation may play a role in fatigue reported by colorectal cancer survivors up to 2 years posttreatment.
Website
Google Scholar
- 2 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
Longitudinal Associations between Inflammatory Markers and Fatigue up to Two Years after Colorectal Cancer Treatment
by Nadira R. Querido, Marlou-Floor Kenkhuis, Eline H. van Roekel, Stéphanie O. Breukink, Fränzel J.B. van Duijnhoven, Maryska L.G. Janssen-Heijnen, Eric T.P. Keulen, Per Magne Ueland, F. Jeroen Vogelaar, Evertine Wesselink, et al.
Background: Fatigue is often reported by colorectal cancer survivors and largely impacts their quality of life. Inflammation has been linked to fatigue mainly in patients with breast cancer. Therefore, we investigated how inflammation is longitudinally associated with fatigue in colorectal cancer survivors, up to 2 years posttreatment. Methods: A total of 257 patients from the ongoing Energy for life after ColoRectal cancer cohort study were included in the analysis. Plasma levels of IL6, IL8, IL10, TNFα, high-sensitivity C-reactive protein (hsCRP), and fatigue were measured at 6 weeks, 6, 12, and 24 months posttreatment. Fatigue was measured through the validated Checklist Individual Strength (CIS; total, 20–140), consisting of four subscales – subjective fatigue (8–56), motivation (4–28), physical activity (3–21), and concentration (5–35), and the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Core 30 fatigue subscale (0–100). Linear mixed-models were used to assess the confounder-adjusted longitudinal associations between inflammatory markers and overall fatigue along with the subscales. Results: Mean levels of CIS fatigue decreased from 62.9 at 6 weeks to 53.0 at 24 months. In general, levels of inflammatory markers also decreased over time. No statistically significant longitudinal associations were found between IL6, IL8, IL10, TNFα, and fatigue. Higher levels of hsCRP were associated with more CIS fatigue (β per SD 3.21, 95% confidence interval (CI), 1.42–5.01) and EORTC fatigue (β 2.41, 95% CI, 0.72–4.10). Conclusions: Increased levels of hsCRP are longitudinally associated with more posttreatment fatigue in colorectal cancer survivors. Impact: These findings suggest that low-grade inflammation may play a role in fatigue reported by colorectal cancer survivors up to 2 years posttreatment.
Cited by 12